頭孢他啶治療產(chǎn)婦產(chǎn)褥期感染的療效與安全性研究
【摘要】目的:探討頭孢他啶治療產(chǎn)褥期產(chǎn)婦感染的療效和安全性。方法:本文選取了2021年6月—2023年4月住院的24名產(chǎn)婦,采用隨機(jī)抽樣方法將其分成兩組,每組12名。對(duì)照組采用左氧氟沙星治療,觀(guān)察組采用頭孢他啶治療,比較兩組的臨床效果及血象各項(xiàng)指標(biāo)。結(jié)果:治療后,觀(guān)察組和對(duì)照組的LYM分別為(39.33±4.48)%和(47.45±6.45)%,MON分別為(6.36±1.44)%和(9.14±1.26)%,GRAN分別為(65.89±1.10)%和(77.43±1.63)%,WBC分別為(7.39±1.43)×109/L和(10.26±1.54)×109/L,觀(guān)察組血象各項(xiàng)指標(biāo)與臨床療效均優(yōu)于對(duì)照組(P
【關(guān)鍵詞】頭孢他啶;產(chǎn)婦;產(chǎn)褥期感染;療效;安全性
Study on the efficacy and safety of ceftazidime in the treatment of puerperal infection in parturients
YANG Yanyan
Chengxian People’s Hospital of Longnan City, Gansu, Longnan, Gansu 742500, China
【Abstract】Objective:To investigate the efficacy and safety of ceftazidime in the treatment of puerperal infection in parturients. Methods:In this study,24 postpartum women hospitalized from June 2021 to April 2023 were selected and divided into two groups using a random sampling method,with 12 women in each group.The control group was treated with levofloxacin,while the observation group was treated with ceftazidime.The clinical effects and various hematological parameters of the two groups were compared.Results:After treatment,the LYM of the observation group and the control group were (39.33±4.48)% and (47.45±6.45)%,the MON were (6.36±1.44)% and (9.14±1.26)%,the GRAN were (65.89±1.10)% and (77.43±1.63)%,and the WBC were (7.39±1.43)×109/L and (10.26±1.54)×109/ L,respectively,and various hematological parameters and clinical efficacy of the observation group were better than those of the control group (P
【Key Words】Ceftazidime; Puerpera; Puerperal infection; Curative effect; Security
產(chǎn)婦在分娩后的產(chǎn)褥期容易發(fā)生感染,常見(jiàn)的感染部位包括子宮、陰道、泌尿道和傷口等。(剩余4037字)
- 產(chǎn)前超聲篩查對(duì)胎兒顱內(nèi)異常的診...
- 心理護(hù)理對(duì)初產(chǎn)婦分娩結(jié)局以及心...
- 宮頸擴(kuò)張球囊聯(lián)合催產(chǎn)素對(duì)足月妊...
- NT超聲檢查在胎兒早孕期結(jié)構(gòu)畸...
- 補(bǔ)腎活血中藥治療多囊卵巢綜合征...
- “三早”健康教育聯(lián)合家庭情感支...
- 阿莫西林鈉克拉維酸鉀治療慢性盆...
- HPV分型檢測(cè)聯(lián)合TCT檢查在...
- 全憑靜脈麻醉及靜吸復(fù)合麻醉對(duì)腹...
- 慢性膽囊炎合并膽囊結(jié)石保守治療...
- 踝關(guān)節(jié)骨折手術(shù)治療和手法復(fù)位治...
- 完全腔鏡經(jīng)胸入路手術(shù)對(duì)甲狀腺乳...
- 增強(qiáng)CT動(dòng)態(tài)掃描對(duì)孤立性肺結(jié)節(jié)...
- 脊髓性肌萎縮癥(SMA)基因篩...
- 神經(jīng)內(nèi)鏡下經(jīng)鼻蝶入路手術(shù)治療垂...
- 頸內(nèi)靜脈穿刺中超聲引導(dǎo)聯(lián)合靜脈...
- 超聲心動(dòng)圖在二葉式主動(dòng)脈瓣(B...
- 內(nèi)鏡下不同術(shù)式在不同部位的結(jié)直...
- 腹腔鏡疝無(wú)張力修補(bǔ)術(shù)治療老年腹...
- 探究左氧氟沙星聯(lián)合頭孢哌酮舒巴...
- 達(dá)格列凈對(duì)急性心肌梗死PCI術(shù)...
- 布地奈德聯(lián)合不同藥物霧化吸入治...
- 氨溴特羅、布地奈德與沙丁胺醇聯(lián)...
- 頭孢他啶治療產(chǎn)婦產(chǎn)褥期感染的療...
- 黃帝內(nèi)針理論指導(dǎo)下針灸治療氣滯...
- 中藥天麻鉤藤飲加減配合針灸治療...
- 慢性萎縮性胃炎合并Hp感染的中...
- 健脾和胃化濁湯治療慢性萎縮性胃...
- 針對(duì)性護(hù)理聯(lián)合中醫(yī)護(hù)理在小兒腹...
- 三維適應(yīng)性支持護(hù)理對(duì)肺炎患兒癥...
- 中醫(yī)護(hù)理聯(lián)合穴位敷貼在小兒支氣...
- 重組人生長(zhǎng)激素對(duì)兒童矮小癥的療...
- 氨溴特羅口服液治療兒童急性支氣...
- 單純性肥胖癥患兒健康膳食指導(dǎo)結(jié)...
- 預(yù)見(jiàn)性護(hù)理在手足口病患兒中的應(yīng)...
- 前庭訓(xùn)練聯(lián)合運(yùn)動(dòng)學(xué)分析法對(duì)運(yùn)動(dòng)...
- 某市2019年10月—2023...
- 優(yōu)質(zhì)護(hù)理在小兒支氣管肺炎患兒護(hù)...
- 綜合護(hù)理用于盆腔炎患者的臨床效...
- 保溫護(hù)理干預(yù)對(duì)婦科宮腔鏡手術(shù)患...
- 探討優(yōu)質(zhì)護(hù)理服務(wù)對(duì)新生兒早產(chǎn)的...
- 全程優(yōu)質(zhì)護(hù)理在妊娠高血壓產(chǎn)婦護(hù)...
- 優(yōu)質(zhì)護(hù)理在上消化道出血患者中的...
- 人性化優(yōu)質(zhì)護(hù)理在呼吸衰竭患者護(hù)...
- 以創(chuàng)傷評(píng)估為基礎(chǔ)的分級(jí)護(hù)理對(duì)急...
- 5步式敘事護(hù)理結(jié)合全程護(hù)理對(duì)門(mén)...
- 康復(fù)護(hù)理干預(yù)對(duì)腰椎間盤(pán)突出癥患...
- 奧倫自理模式在糖尿病腎病患者護(hù)...
- 辨證飲食護(hù)理對(duì)2型糖尿病患者飲...
- 護(hù)理干預(yù)對(duì)乳腺癌術(shù)后患者患肢功...
- 綜合護(hù)理干預(yù)在腦梗死后認(rèn)知功能...
- 綜合護(hù)理干預(yù)對(duì)老年糖尿病患者睡...
- 延續(xù)性護(hù)理干預(yù)對(duì)難治性肺結(jié)核患...
- 信息化延伸護(hù)理在規(guī)律透析患者中...
- 優(yōu)質(zhì)護(hù)理對(duì)胃腸鏡手術(shù)患者手術(shù)時(shí)...
- 心理護(hù)理干預(yù)在功能性胃腸病患者...
- 門(mén)診營(yíng)養(yǎng)護(hù)理干預(yù)對(duì)晚期胃腸道腫...
- 臨床護(hù)理路徑在血栓閉塞性脈管炎...
- 舒適護(hù)理改善肛周膿腫患者術(shù)后疼...
- 舒適護(hù)理結(jié)合改進(jìn)型側(cè)臥位體位墊...
- 分級(jí)護(hù)理管理對(duì)重癥監(jiān)護(hù)室感染性...
- 男護(hù)士對(duì)手術(shù)室儀器設(shè)備統(tǒng)籌管理...
- 心理護(hù)理干預(yù)用于體檢中心健康管...
- 老年糖尿病患者護(hù)理干預(yù)的臨床效...
- 持續(xù)質(zhì)量改進(jìn)在婦幼保健院院感質(zhì)...
- 個(gè)性化家庭醫(yī)生簽約服務(wù)在65歲...